Computed tomography densitometry and morphology of radiofrequency ablated Stage IA non-small cell lung cancer: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial Alexander, Erica S. , Xiong, Lillian , Baird, Grayson L. ... - - J Vasc Interv Radiol - 2020 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4033
Mutations associated with a 17-gene leukemia stem cell score and the score's prognostic relevance in the context of the European LeukemiaNet classification of acute myeloid leukemia. Bill, Marius , Nicolet, Deedra , Kohlschmidt, Jessica ... - - Haematologica - 2020 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Leuk Corr Sci - C8621 , CALGB-8461 , C8721 , CALGB-10201 , CALGB-10502 , CALGB-10503 , CALGB-10603 , CALGB-11001 , CALGB-11002 , CALGB-19808 , CALGB-20202 , CALGB-8525 , CALGB-8821 , CALGB-8923 , CALGB-9022 , CALGB-9120 , CALGB-9222 , CALGB-9420 , CALGB-9621 , CALGB-9665 , CALGB-9720
Final report from intergroup NCCTG 86-72-51 (Alliance): a phase 3 randomized clinical trial of high dose versus low dose radiation for adult low-grade glioma. Breen, William G , Anderson, S Keith , Carrero, Xiomara W ... - - Neuro-oncology - 2020 Manuscript - Primary Endpoint - Long-Term-Followup Analysis - Neuro-Onc - NCCTG-86-72-51
Attitudes of Clinicians about Screening Head and Neck Cancer Survivors for Lung Cancer Using Low-Dose Computed Tomography Dukes, Kimberly , Seaman, Aaron T. , Hoffman, Richard M. ... - - Ann. Otol. Rhinol. Laryngol. - 2020 Manuscript - No-Endpoint Endpoint - Primary Analysis - Prevention - Pilot
Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor-Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance). Hwang, E Shelley , Hyslop, Terry , Hendrix, Laura H ... - - J. Clin. Oncol. - 2020 Manuscript - Primary Endpoint - Primary Analysis - Breast - CALGB-40903
Nomogram-based estimate of axillary nodal involvement in ACOSOG Z0011 (Alliance): validation and association with radiation protocol variations. Katz, Matthew S , McCall, Linda , Ballman, Karla , Jagsi, Reshma ... - - Breast Cancer Res. Treat. - 2020 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Breast - ACOSOG-Z0011
Musculoskeletal side effects over time and the association of side effects and adherence in women taking neoadjuvant letrozole for estrogen receptor positive DCIS (CALGB 40903) Kimmick, Gretchen , Dueck, Amylou C. , Shelby, Rebecca ... - SABCS - Cancer Res - 2020 Abstract - Secondary Endpoint - Primary Analysis - Health Outcome - CALGB-40903
Geriatric assessment among older adults receiving intensive therapy for acute myeloid leukemia: Report of CALGB 361006 (Alliance). Klepin, Heidi D , Ritchie, Ellen , Major-Elechi, Brittny ... - - J Geriatr Oncol - 2020 Manuscript - Primary Endpoint - Primary Analysis - Older Adult - CALGB-361006
Neurological safety of oxaliplatin in patients with uncommon variants in Charcot-Marie-Tooth disease genes. Le-Rademacher, Jennifer G , Lopez, Camden L , Kanwar, Rahul ... - - J. Neurol. Sci. - 2020 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Symptom Inter - N08CB
Analysis of tumor microenvironmental features to refine prognosis by T, N risk group in patients with stage III colon cancer (NCCTG N0147) (Alliance). Lee, H , Sha, D , Foster, N R , Shi, Q , Alberts, S R , Smyrk, T C ... - - Ann. Oncol. - 2020 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - N0147
Randomized phase II trial and tumor mutational spectrum analysis from cabozantinib versus chemotherapy in metastatic uveal melanoma (Alliance A091201) Luke, Jason J. , Olson, Daniel J. , Allred, Jacob B. ... - - Clin. Cancer Res. - 2020 Manuscript - Primary Endpoint - Primary Analysis - Experimental - A091201
Serial analysis of circulating tumor cells identifies four prognostic groups for novel risk-stratification in metastatic breast cancer (CALGB 40502/NCCTG N063H) (Alliance) Magbanua, Mark Jesus M. , Hendrix, Laura H. , Hyslop, Terry ... - AACR-ALB - - 2020 Abstract - Secondary Endpoint - Primary Analysis - Correl Sci NOS - CALGB-40502
Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801 Marcucci, Guido , Geyer, Susan , Laumann, Kristina , Zhao, Weiqiang ... - - Blood Adv - 2020 Manuscript - Primary Endpoint - Primary Analysis - Leukemia - CALGB-10801 , CALGB-20202
Effect of a Behavioral Intervention to Increase Vegetable Consumption on Cancer Progression Among Men With Early-Stage Prostate Cancer Parsons, J. Kellogg , Zahrieh, David , Mohler, James L. ... - - JAMA - 2020 Manuscript - Primary Endpoint - Primary Analysis - Prevention - CALGB-70807
Androgen Decline and Survival During Docetaxel Therapy in metastatic Castration Resistant Prostate Cancer (mCRPC) Ryan, Charles J , Dutta, Sandipan , Kelly, William K , Russell, Carly ... - - Prostate Cancer Prostatic Dis. - 2020 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GU - CALGB-90401
A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study. Schenk, Erin L , Mandrekar, Sumithra J , Dy, Grace K ... - - J Thorac Oncol - 2020 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - N0923
Multisite, Randomized Trial of Early Integrated Palliative and Oncology Care in Patients with Advanced Lung and Gastrointestinal Cancer: Alliance A221303. Temel, Jennifer S , Sloan, Jeff , Zemla, Tyler , Greer, Joseph A ... - - J Palliat Med - 2020 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - A221303
Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3). Trifiletti, Daniel M , Ballman, Karla V , Brown, Paul D ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2020 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Neuro-Onc - N107C
Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Alliance) Xie, Hao , Lafky, Jacqueline M. , Morlan, Bruce W. ... - - Ther Adv Med Oncol - 2020 Manuscript - Primary Endpoint - Primary Analysis - GI - N054C
